The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
Abstract
Cyclosporin A, FK506, and rapamycin are inhibitors of specific signal transduction pathways that lead to T lymphocyte activation. These immunosuppressive agents bind with high affinity to cytoplasmic receptors termed immunophilins (immunosuppressant binding proteins). Studies in this area have focused on the structural basis for the molecular recognition of immunosuppressants by immunophilins and the biological consequences of their interactions. Defining the biological roles of this emerging family of receptors and their ligands may illuminate the process of protein trafficking in cells and the mechanisms of signal transmission through the cytoplasm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The natural product rapamycin binds to FKBP12, leading to the recruitment of mTORC1, resulting in partial inhibition of mTORC1 7.”
From Manumycin polyketides act as molecular glues between UBR7 and P53 (2020) · cites this paper as [7]
Citations
Cites
Cyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin A
Handschumacher, R. E., Harding, M. W., Rice, J. S., Drugge, R. J., & Speicher, D. W. (1984) · Science · doi:10.1126/science.6238408 · Cited by 1,675
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
Fischer, G., Wittmann‐Liebold, B., Lang, K., Kiefhaber, T., & Schmid, F. X. (1989) · Nature · doi:10.1038/337476a0 · Cited by 1,408
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Gałat, A., Uehling, D., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,396
Self-citationOates, J. A., Wood, A. J. J., & Kahan, B. D. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912213212507 · Cited by 1,351
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin
Takahashi, N., Hayano, T., & Suzuki, M. (1989) · Nature · doi:10.1038/337473a0 · Cited by 1,075
Contingent Genetic Regulatory Events in T Lymphocyte Activation
Crabtree, G. R. (1989) · Science · doi:10.1126/science.2783497 · Cited by 1,071
FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
Starzl, T., Fung, J. J., Venkataraman, R., Todo, S., Demetris, A. J., & Jain, A. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91014-3 · Cited by 1,036
Siekierka, J. J., Hung, S. H. Y., Poe, M., Lin, C. S., & SIGAL, N. H. (1989) · Nature · doi:10.1038/341755a0 · Cited by 1,016
Identification of a Putative Regulator of Early T Cell Activation Genes
Shaw, J., Utz, P. J., Durand, D. B., Toole, J. J., Emmel, E. A., & Crabtree, G. R. (1988) · Science · doi:10.1126/science.3260404 · Cited by 946
Polypeptide chain binding proteins: Catalysts of protein folding and related processes in cells
Rothman, J. E. (1989) · Cell · doi:10.1016/0092-8674(89)90005-6 · Cited by 887
Flagged first, then by citations
1 of the 56 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Bierer, B. E., Proceedings of the National Academy of Sciences of the United States of America 87: 9231 (1990).
- Matila P. S. EMBO Journal in press.
Cited by
Sorted by citations
Items 601–700 of 1,002
Naturstoffe als Sonden zum Studium zellulärer Funktionen – Untersuchungen von Immunophilinen
Rosen, M. K., & Schreiber, S. L. (1992) · Angewandte Chemie · doi:10.1002/ange.19921040406 · Cited by 43
Self-citationInsights into peptidyl-prolyl cis–trans isomerase structure and function in immunocytes
Nath, P. R., & Isakov, N. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.11.002 · Cited by 42
Fluoresceinated FKBP12 ligands for a high-throughput fluorescence polarization assay
Dubowchik, G. M., Ditta, J. L., Herbst, J. J., Bollini, S., & Vinitsky, A. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00045-7 · Cited by 42
Sachewsky, N., Hunt, J., Cooke, M. J., Azimi, A., Zarin, T., Miu, C., Shoichet, M. S., & Morshead, C. M. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.014480 · Cited by 42
Game of TOR — The Target of Rapamycin Rules Four Kingdoms
Manning, B. D. (2017) · New England Journal of Medicine · doi:10.1056/nejmcibr1709384 · Cited by 42
Chiba, K. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0351-0 · Cited by 42
The Effects of Rapamycin in Murine Peripheral Nerve Isografts and Allografts
Myckatyn, T. M., Ellis, R. A., Grand, A. G., Sen, S. K., Lowe, J. B., Hunter, D. A., & Mackinnon, S. E. (2002) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200206000-00035 · Cited by 42
From theory to therapy: Implications from an in vitro model of ramified microglia
Rosenstiel, P. C., Lucius, R., Deuschl, G., Sievers, J., & Wilms, H. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1116 · Cited by 42
Lee, J. S., & Lee, G. M. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24567 · Cited by 45
Protection Provided by Cyclosporin A against Excitotoxic Neuronal Death Is Genotype Dependent
Santos, J. B., & Schauwecker, P. E. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.66302.x · Cited by 42
Luengo, J. I., Yamashita, D. S., Dunnington, D. J., Beck, A., Rozamus, L. W., Yen, H.-K., Bossard, M. J., Levy, M. A., Hand, A. T., Newman‐Tarr, T., et al. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90264-3 · Cited by 41
Waal, E. J. D., Schuurman, H., Loveren, H. V., & Vos, J. G. (1997) · Critical Reviews in Toxicology · doi:10.3109/10408449709089900 · Cited by 42
Funk, J. O., Ernst, M., Schönharting, M., & Zabel, P. (1995) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(95)00096-8 · Cited by 42
Gold, B. G., Udina, E., BOURDETTE, D. N., & Navarro, X. (2004) · Neurological Research · doi:10.1179/016164104225013734 · Cited by 42
Escher, A., Szalay, A. A., Tropschug, M., Kruse, M., Brunke, M. A., & Zimmermann, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2588 · Cited by 42
Renoir, J., Bihan, S. L., Mercier-Bodard, C., Gold, A., Arjomandi, M., Radanyi, C., & Baulieu, É.-É. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90256-9 · Cited by 42
Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.Preprint
Alarcón, C. M., Cardenas, M. E., & Heitman, J. (1996) · Genes & Development · doi:10.1101/gad.10.3.279 · Cited by 42
Belizentrin, a Highly Bioactive Macrocycle from the Dinoflagellate Prorocentrum belizeanum
Domínguez, H. J., Napolitano, J. G., Fernández‐Sánchez, M. T., Cabrera-García, D., Novelli, A., Norte, M., Fernández, J. J., & Daranas, A. H. (2014) · Organic Letters · doi:10.1021/ol502102f · Cited by 41
Chen, Q., Chen, Q., Sun, G., Zheng, K., Yao, Z., Han, Y., Wang, L.-P., Duan, Y., Yu, D., & Qu, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020349 · Cited by 41
Cyclosporin A prodrugs: design, synthesis and biophysical properties
Hamel, A., Hubler, F., Carrupt, A., Wenger, R. M., & Mutter, M. (2004) · Journal of Peptide Research · doi:10.1111/j.1399-3011.2003.00111.x · Cited by 41
Chemical genomics in the global study of protein functions
Zheng, X.-F., & Chan, T. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02118-3 · Cited by 41
Gerez, L., Mohrmann, K., van Raak, M., Jongeneelen, M. A. C., Zhou, X. Z., Lu, K. P., & van der Sluijs, P. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.7.2201 · Cited by 41
Sandborn, W. J., Lawson, G. M., Cody, T. J., Porayko, M. K., Hay, E. J., Gores, G. J., Steers, J. L., Krom, R. A. F., & Wiesner, R. H. (1995) · Hepatology · doi:10.1002/hep.1840210113 · Cited by 41
Mechanism for the rotamase activity of FK506 binding protein from molecular dynamics simulations
Orozco, M., Tirado‐Rives, J., & Jorgensen, W. L. (1993) · Biochemistry · doi:10.1021/bi00210a040 · Cited by 41
Matts, R. L., & Hurst, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37168-6 · Cited by 41
cDNA Cloning of a human 5 kDa FK506 and rapamycin binding protein
Hung, D. T., & Schreiber, S. L. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90651-z · Cited by 41
Self-citationParker, E., Monopoli, A., Ongini, E., Lozza, G., & Babij, C. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00028-9 · Cited by 45
Chambraud, B., Radanyi, C., Camonis, J., Rajkowski, K. M., Schumacher, M., & Baulieu, É.-É. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2104 · Cited by 41
Paterson, I., & Wren, S. P. (1993) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39930001790 · Cited by 41
Soe, N. N., Sowden, M. P., Baskaran, P., Smolock, E. M., Kim, Y., Nigro, P., & Berk, B. C. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301894 · Cited by 40
Functional Drift of Sequence Attributes in the FK506-Binding Proteins (FKBPs)
Gałat, A. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700429n · Cited by 39
Effects of tacrolimus on ischemia-reperfusion injury
Peter, S. D. S., Moss, A. A., & Mulligan, D. C. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50020 · Cited by 40
Ingelsson, B., Shapiguzov, A., Kieselbach, T., & Vener, A. V. (2009) · Plant and Cell Physiology · doi:10.1093/pcp/pcp122 · Cited by 40
Identification and Characterization of Harc, a Novel Hsp90-associating Relative of Cdc37
Scholz, G. M., Cartledge, K., & Hall, N. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103889200 · Cited by 40
Rapamycin Inhibits Corneal Allograft Rejection and Neovascularization
Olsen, T. W. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090230085026 · Cited by 40
Structure of Rapamycin: An NMR and Molecular‐Dynamics Investigation
Kessler, H., Haeßner, R., & Schüler, W. (1993) · Helvetica Chimica Acta · doi:10.1002/hlca.19930760106 · Cited by 40
Neisseria meningitidis encodes an FK506-inhibitable rotamase.
Sampson, B. A., & Gotschlich, E. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1164 · Cited by 40
Komba, S., Galustian, C., Ishida, H., Feizi, T., Kannagi, R., & Kiso, M. (1999) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(19990419)111:8 · Cited by 5
Wiederrecht, G., & Etzkorn, F. A. (1994) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171737 · Cited by 40
Targeting CaN/NFAT in Alzheimer’s brain degeneration
Mackiewicz, J., Lisek, M., & Boczek, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1281882 · Cited by 41
Fragment-based domain shuffling approach for the synthesis of pyran-based macrocycles
Comer, E., Liu, H., Joliton, A., Clabaut, A., Johnson, C., Akella, L. B., & Marcaurelle, L. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015255108 · Cited by 39
Gotchev, D. B., & Comins, D. L. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo061677t · Cited by 39
FKBPs and their role in neuronal signaling
Hausch, F. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.012 · Cited by 39
Chakraborty, A., Das, I. R., Datta, R., Sen, B., Bhattacharyya, D., Mandal, C., & Datta, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204827200 · Cited by 39
Gramberg, D., & Robinson, J. A. (1994) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)75983-1 · Cited by 39
Immunopathogenesis and Immunotherapy of Psoriasis
Griffiths, T. W., Griffiths, C. E. M., & Voorhees, J. J. (1995) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30038-x · Cited by 39
Horizons in pharmacologic intervention in allergic contact dermatitis
Funk, J. O., & Maibach, H. I. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70272-1 · Cited by 39
INBIBITION OF LIVER, KIDNEY, AND INTESTINE REGENERATION BY RAPAMYCIN
Porter, K. A., & Schreiber, S. L. (1992) · Transplantation · doi:10.1097/00007890-199202010-00045 · Cited by 39
Self-citationThe yeast cyclophilin multigene family: purification, cloning and characterization of a new isoform
McLaughlin, M. M., Bossard, M. J., Koser, P. L., Cafferkey, R., Morris, R. A., Miles, L. M., Strickler, J. E., Bergsma, D. J., Levy, M. A., & Livi, G. P. (1992) · Gene · doi:10.1016/0378-1119(92)90606-p · Cited by 39
Mok, D., Allan, R. K., Carrello, A., Wangoo, K., Walkinshaw, M. D., & Ratajczak, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.039 · Cited by 37
Dick, R. A., Kamynina, E., & Vogt, V. M. (2013) · Journal of Virology · doi:10.1128/jvi.01659-13 · Cited by 38
Hung, M.-C., Salim, O., Williams, J. N., Heckels, J. E., & Christodoulides, M. (2011) · Infection and Immunity · doi:10.1128/iai.05019-11 · Cited by 38
Nishimura, S., & Matsumori, N. (2020) · Natural Product Reports · doi:10.1039/c9np00059c · Cited by 37
Murine Creld1 Controls Cardiac Development through Activation of Calcineurin/NFATc1 Signaling
Mass, E., Wachten, D., Aschenbrenner, A. C., Voelzmann, A., & Hoch, M. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.02.012 · Cited by 38
Cumino, A. C., Lamenza, P., & Denegri, G. M. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.11.011 · Cited by 38
Hueros, G., Rahfeld, J., Salamini, F., & Thompson, R. (1998) · Planta · doi:10.1007/s004250050303 · Cited by 38
Sauer, H., Francis, J. M., Jiang, H., Hamilton, G. S., & Steiner, J. P. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01851-x · Cited by 38
Protein targets for structure‐based drug design
Walkinshaw, M. D. (1992) · Medicinal Research Reviews · doi:10.1002/med.2610120403 · Cited by 38
Sezen, S. F., Blackshaw, S., Steiner, J. P., & Burnett, A. L. “. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900919 · Cited by 38
Hansen, K. H., Lukas, J., Holm, K., Kjerulff, A. A., & Bártek, J. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19990201)20:2 · Cited by 8
Tacrolimus (FK506) Attenuates Leukocyte Accumulation After Transient Retinal Ischemia
Tsujikawa, A., Ogura, Y., Hiroshiba, N., Miyamoto, K., Kiryu, J., & Honda, Y. (1998) · Stroke · doi:10.1161/01.str.29.7.1431 · Cited by 38
Rowling, P. J. E., & Freedman, R. B. (1993) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4615-2912-5_3 · Cited by 38
Natural Product-Inspired Targeted Protein Degraders: Advances and Perspectives
Li, J., Cai, Z., Li, X., & Zhuang, C. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01223 · Cited by 39
Catalytic asymmetric direct aldol reaction of α-alkyl azlactones and aliphatic aldehydes
Zheng, Y., & Deng, L. (2015) · Chemical Science · doi:10.1039/c5sc02116b · Cited by 37
Nitta, A., Nishioka, H., Fukumitsu, H., Furukawa, Y., Sugiura, H., Shen, L., & Furukawa, S. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20258 · Cited by 37
Structure-based design of novel calcineurin (PP2B) inhibitors
Tatlock, J. H., Linton, M. A., Hou, X., Kissinger, C. R., Pelletier, L. A., Showalter, R. E., Tempczyk, A., & Villafranca, J. E. (1997) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(97)00141-8 · Cited by 37
Solution structure of FK506 bound to FKBP‐12
Lepre, C. A., Thomson, J. A., & Moore, J. M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80292-o · Cited by 37
Ghosh, D., Mueller, G. A., Schramm, G., Edwards, L. L., Petersen, A., London, R. E., Haas, H., & Bhattacharya, S. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559971 · Cited by 36
Structures of Pathogenic Fungal FKBP12s Reveal Possible Self-Catalysis Function
Tonthat, N. K., Juvvadi, P. R., Zhang, H., Lee, S. C., Venters, R. A., Spicer, L. D., Steinbach, W. J., Heitman, J., & Schumacher, M. A. (2016) · mBio · doi:10.1128/mbio.00492-16 · Cited by 36
The structure of FKBP38 in complex with the MEEVD tetratricopeptide binding-motif of Hsp90
Blundell, K. L. I. M., Pal, M., Roe, S. M., Pearl, L. H., & Prodromou, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173543 · Cited by 36
Kaur, G., Singh, S., Singh, H., Chawla, M., Dutta, T., Kaur, H., Bender, K. W., Snedden, W. A., Kapoor, S., Pareek, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136692 · Cited by 36
Kaihara, S., Bessho, K., Okubo, Y., Sonobe, J., Kawai, M. Y., & IIZUKA, T. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302176 · Cited by 36
FR177391, A New Anti-hyperlipidemic Agent from Serratia
Sato, B., Nakajima, H., Fujita, T., Takase, S., Yoshimura, S., Kinoshita, T., & Terano, H. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.87 · Cited by 36
Padilla, P. I., Chang, M.-J., Pacheco–Rodriguez, G., Adamik, R., Moss, J., & Vaughan, M. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2628047100 · Cited by 36
Intramolecular Catalysis of Amide Isomerization
Cox, C. D., Young, V. G., & Lectka, T. (1997) · Journal of the American Chemical Society · doi:10.1021/ja964017m · Cited by 36
Synthetic studies on antascomicin A: construction of the C18–C34 fragment
Fuwa, H., Okamura, Y., & Natsugari, H. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.04.072 · Cited by 36
Bonnefoy, N., Verrier, B., Vincent, C., & Révillard, J. P. (1992) · PubMed Central · Cited by 36
Chaperones and protein folding
Kelley, W. L., & Georgopoulos, C. P. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90130-5 · Cited by 36
Glucocorticoid Therapy of Spinal Cord Injurya
Young, W., Kume‐Kick, J., & Constantini, S. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb55796.x · Cited by 36
Discovery of fully synthetic FKBP12-mTOR molecular glues
Deutscher, R. C. E., Meyners, C., Repity, M. L., Sugiarto, W. O., Kolos, J., Maciel, E. V. S., Heymann, T., Geiger, T. M., Knapp, S., Lermyte, F., et al. (2025) · Chemical Science · doi:10.1039/d4sc06917j · Cited by 39
Park, H. J., You, Y. N., Lee, A., Jung, H., Jo, S. H., Oh, N., Kim, H., Lee, H., Kim, J., Kim, Y. S., et al. (2020) · The Plant Journal · doi:10.1111/tpj.14682 · Cited by 35
Seyfinejad, B., & Jouyban, A. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114315 · Cited by 35
Sakaguchi, M., Sonegawa, H., Nukui, T., Sakaguchi, Y. M., Miyazaki, M., Namba, M., & Huh, N.-H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500630102 · Cited by 35
Siemion, I. Z., Cebrat, M., & Wieczorek, Z. J. (1999) · PubMed · Cited by 35
TACROLIMUS FOR PRIMARY TREATMENT OF STEROID-RESISTANT HEPATIC ALLOGRAFT REJECTION
Millis, J. M., Woodle, E. S., Piper, J. B., Bruce, D. S., Newell, K. A., Seaman, D. S., Baker, A. L., Hart, J., Dasgupta, K., & Thistlethwaite, J. R. (1996) · Transplantation · doi:10.1097/00007890-199605150-00014 · Cited by 35
Solvent Effects on the Barrier to C−N Bond Rotation in N,N-Dimethylaminoacrylonitrile
Rablen, P. R., Miller, D. A., Bullock, V. R., Hutchinson, P. H., & Gorman, J. A. (1998) · Journal of the American Chemical Society · doi:10.1021/ja982304f · Cited by 35
Schmidt, A., Hall, M. N., & Koller, A. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6597-6606.1994 · Cited by 35
The role of proline 345 in diphtheria toxin translocation.
Johnson, V. G., NICHOLLS, P. J., Habig, W. H., & Youle, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53724-8 · Cited by 35
Novel Bicyclic Lactams as XaaPro Type VI β Turn Mimics: Design, Synthesis, and Evaluation
Kim, K., Dumas, J., & Germanas, J. P. (1996) · The Journal of Organic Chemistry · doi:10.1021/jo960012w · Cited by 35
Prévilon, M., Gall, M. L., Chafey, P., Federeci, C., Pezet, M., Clary, G., Broussard, C., Guillonneau, F., Mercadier, J.-J., & Rouet‐Benzineb, P. (2013) · Physiological Reports · doi:10.1002/phy2.39 · Cited by 34
Gałat, A. (2004) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2004.01.004 · Cited by 35
Differences between cyclosporin A and tacrolimus in organ transplantation
Jiang, H., & Kobayashi, M. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(99)00235-3 · Cited by 34
Structure-activity studies of synthetic FKBP ligands as peptidyl-prolyl isomerase inhibitors
Holt, D. A., Konialian-Beck, A. L., Oh, H.-J., Yen, H.-K., Rozamus, L. W., Krog, A. J., Erhard, K. F., Ortiz, E., Levy, M. A., Brandt, M. A., et al. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80135-9 · Cited by 34
Yamamoto-Yamaguchi, Y., Okabe‐Kado, J., Kasukabe, T., & Honma, Y. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00626-9 · Cited by 34
Crystal structures of cyclophilin and its partners
Ke, H. (2004) · Frontiers in bioscience · doi:10.2741/1396 · Cited by 33
Progress towards a molecular understanding of cyclosporin A-mediated immunosuppression
Schumacher, A., & Nordheim, A. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00180747 · Cited by 34
Cardenas, M. E., Lim, E. Q., & Heitman, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.20997 · Cited by 34
Jain, A. K., Khanna, A., Molmenti, E. P., Rishi, N., & Fung, J. J. (1999) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70007-4 · Cited by 34
Schwaninger, M., Blume, R., Oetjen, E., & Knepel, W. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00173216 · Cited by 34
Cardenas, M. E., Lorenz, M. C., Hemenway, C. S., & Heitman, J. (1994) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171739 · Cited by 34
Metadata
- Authors
- Schreiber, S. L.
- Affiliations
- Harvard University (US)
- Corresponding author
- Schreiber, Stuart L.
- ORCID
- Schreiber, Stuart L.
- Venue
- Science
- Published
- 1991-01-18
- Volume
- 251
- Issue
- 4991
- Pages
- 283-287
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2024842574
- Cited by
- 1,494
- References
- 56
- Citations by year
- 2026: 7 · 2025: 21 · 2024: 13 · 2023: 18 · 2022: 17 · 2021: 21 · 2020: 13 · 2019: 15 · 2018: 12 · 2017: 19 · 2016: 23 · 2015: 27 · 2014: 28 · 2013: 34 · 2012: 23
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM38627)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › S100 Proteins and Annexins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- immunophilins, cyclosporine, FK506, rapamycin, T cell activation, signal transduction inhibition, protein trafficking, molecular recognition, protein-ligand binding
- MeSH terms
- Amino Acid Isomerases, Animals, Anti-Bacterial Agents, Carrier Proteins, Cyclosporins, Humans, Immunosuppressive Agents, Isomerases, Ligands, Lymphocyte Activation, Polyenes, Receptors, Immunologic, T-Lymphocytes, Tacrolimus, Peptidylprolyl Isomerase, Sirolimus, Tacrolimus Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review